Emergent Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Gastric Variceal Bleeding in Patients with Hepatocellular Carcinoma.

[1]  Xiao Li,et al.  Transjugular intrahepatic portosystemic shunt creation for the prevention of gastric variceal rebleeding in patients with hepatocellular carcinoma: a multicenter retrospective study. , 2021, Journal of vascular and interventional radiology : JVIR.

[2]  R. Gaba,et al.  Emergent Transjugular Intrahepatic Portosystemic Shunt Creation in Acute Variceal Bleeding , 2020, Seminars in Interventional Radiology.

[3]  Xiao Li,et al.  Transjugular intrahepatic portosystemic shunt creation for portal hypertension in patients with hepatocellular carcinoma: A systematic review , 2018, Gastrointestinal Intervention.

[4]  Thomas G. Walker,et al.  Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice Committee. , 2017, Journal of vascular and interventional radiology : JVIR.

[5]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[6]  J. Minocha,et al.  MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. , 2015, Annals of hepatology.

[7]  D. Bettinger,et al.  Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma , 2015, Alimentary pharmacology & therapeutics.

[8]  D. Fan,et al.  Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  R. Testa,et al.  Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  Ziv J Haskal,et al.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension , 2005, Hepatology.

[11]  P. Hayes,et al.  The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations , 2002 .

[12]  A. Burroughs,et al.  "Salvage" Transjugular Intrahepatic Portosystemic Shunts: Gastric Fundal Compared With Esophageal Variceal Bleeding , 1998 .

[13]  P. Hayes,et al.  A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS) , 1997, Alimentary pharmacology & therapeutics.

[14]  S. Sarin,et al.  Prevalence, classification and natural history of gastric varices: A long‐term follow‐up study in 568 portal hypertension patients , 1992, Hepatology.

[15]  R. de Franchis.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.